Chronic
inflammation is one of the predisposing factors for neoplastic transformation. Targeting
inflammation through suppression of the pro-inflammatory pathway by
dietary phytochemicals provides an important strategy for
cancer prevention.
Maslinic acid is a novel natural
triterpenoid known to inhibit proliferation and induce apoptosis in some tumor cell lines. Although
maslinic acid has cytotoxic and pro-apoptotic effects on
cancer cells, the underlying mechanisms of its effects on the inflammatory pathway have yet to be elucidated. It has been reported that abnormal expression of pro-inflammatory
enzyme cyclooxygenase-2 (COX-2) causes promotion of cellular proliferation, suppression of apoptosis, enhancement of angiogenesis and invasiveness. In the present study, the suppressive effect of
maslinic acid on COX-2 expression and the binding activity of upstream
transcription factors NF- κB and
AP-1, which are known to regulate COX-2 transcriptional activation, were assessed using Raji cells. The anti-inflammatory action of
maslinic acid was benchmarked against
oleanolic acid and other standard drugs. Western blot analysis and electrophoretic mobility shift assay (EMSA) were employed to analyze COX-2 expression as well as NF- κB and
AP-1 binding activity. Our results showed that
maslinic acid suppresses COX-2 expression in a concentration-dependent manner. Likewise, the constitutive nuclear NF- κB (p65) activity as well as
phorbol 12-myristate 13-acetate (PMA)- and
sodium N-butyrate (SnB)-induced
AP-1 binding activity in Raji cells were significantly reduced following treatment with
maslinic acid. Since
maslinic acid suppresses COX-2 expression in Raji cells at concentrations that also lowered the NF- κB (p65) and
AP-1 binding activity, it is possible that the suppression of COX-2 by this natural
triterpenoid might be achieved, at least in part, via the NF- κB and
AP-1 signaling pathways.